Report cover image

Middle East Pharmaceutical Excipient Market Size, Share & Trends Analysis Report By Product (Polymers, Alcohols, Sugar & Others, Minerals), By Formulation (Oral, Topical), By Function (Binders, Lubricants & Glidants), By Country, And Segment Forecasts, 20

Publisher Grand View Research
Published Sep 01, 2025
Length 150 Pages
SKU # GV20470927

Description

Market Size & Trends

The Middle East pharmaceutical excipient market size was estimated at USD 278.93 million in 2024 and is projected to reach USD 354.71 million by 2033, growing at a CAGR of 2.69% from 2025 to 2033. The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders has led to a higher demand for effective formulations that rely on advanced excipients. Rising health awareness and greater access to medical treatments are increasing prescription volumes across the region. Excipients are gaining importance as they enhance solubility, bioavailability, and stability of drugs in challenging formulations. With more patients requiring long-term therapies, controlled release and patient-friendly dosage forms are seeing higher demand. This trend is creating opportunities for excipients that improve drug delivery and compliance. As the need for innovative medicines grows, excipients are emerging as essential components in regional drug development.

Another factor driving the growth of the market is the rapid advancement of pharmaceutical technologies and formulation science. Co-processed excipients are being adopted to simplify production processes, reduce variability, and improve product performance. The shift towards complex biologics and sensitive drug molecules has accelerated the need for specialized excipients with enhanced compatibility. Nanotechnology-based excipients are enabling precise targeting and efficient delivery of active ingredients. Oral solid dosage forms remain dominant in the region, and the innovation of excipients tailored for tablets and capsules is fueling consistent demand.

For instance, in November 2023, Roquette introduced three new excipients, Lycatab CT-LM, Microcel 103 SD, and Microcel 113 SD, during the October CPHI Barcelona trade show. Lycatab CT-LM, a pre-gelatinized starch, was highlighted as a multifunctional excipient functioning as a filler, binder, and disintegrant, with an extremely low water activity (Aw) of no more than 0.1%, making it suitable for dry granulation, hard capsule filling, and direct compression processes.

Middle East Pharmaceutical Excipient Market Report Segmentation

This report forecasts revenue at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East pharmaceutical excipient market report based on product, formulation, function, and country:
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Polymers
  • MCC
  • HPMC
  • Ethyl Cellulose
  • Methyl Cellulose
  • CMC
  • Croscarmellose Sodium
  • Povidone
  • Pregelatinized starch
  • Sodium starch glycolate
  • Polyethylene Glycol
  • Acrylic Polymers
  • Alcohol
  • Glycerin
  • Propylene Glycol
  • Sorbitol
  • Mannitol
  • Others
  • Sugar & Others
  • Lactose
  • Sucrose
  • Others
  • Minerals
  • Calcium Phosphate
  • Calcium Carbonate
  • Clay
  • Silicon Dioxide
  • Titanium Dioxide
  • Others
  • Gelatin
  • Formulation Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Topical
  • Parenteral
  • Others
  • Function Outlook (Revenue, USD Million, 2021 - 2033)
  • Fillers and Diluents
  • Suspending & Viscosity Agents
  • Coating Agents
  • Binders
  • Flavoring Agents & Sweeteners
  • Disintegrants
  • Colorants
  • Lubricants and Glidants
  • Preservatives
  • Emulsifying Agents
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman
  • Rest of Middle East
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

150 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Formulation
1.2.3. Function
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Middle East Pharmaceutical Excipient Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Middle East Pharmaceutical Excipient Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2033
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Polymers
4.4.1. Polymers Market, 2021 - 2033 (USD Million)
4.4.2. MCC
4.4.2.1. MCC Market, 2021 - 2033 (USD Million)
4.4.3. HPMC
4.4.3.1. HPMC Market, 2021 - 2033 (USD Million)
4.4.4. Ethyl Cellulose
4.4.4.1. Ethyl Cellulose Market, 2021 - 2033 (USD Million)
4.4.5. Methyl Cellulose
4.4.5.1. Methyl Cellulose Market, 2021 - 2033 (USD Million)
4.4.6. CMC
4.4.6.1. CMC Market, 2021 - 2033 (USD Million)
4.4.7. Croscarmellose Sodium
4.4.7.1. Croscarmellose Sodium Market, 2021 - 2033 (USD Million)
4.4.8. Povidone
4.4.8.1. Povidone Market, 2021 - 2033 (USD Million)
4.4.9. Pregelatinized starch
4.4.9.1. Pregelatinized starch Market, 2021 - 2033 (USD Million)
4.4.10. Sodium starch glycolate
4.4.10.1. Sodium starch glycolate Market, 2021 - 2033 (USD Million)
4.4.11. Polyethylene Glycol
4.4.11.1. Polyethylene Glycol Market, 2021 - 2033 (USD Million)
4.4.12. Acrylic Polymers
4.4.12.1. Acrylic Polymers Market, 2021 - 2033 (USD Million)
4.5. Alcohol
4.5.1. Alcohol Market, 2021 - 2033 (USD Million)
4.5.2. Glycerin
4.5.2.1. Glycerin Market, 2021 - 2033 (USD Million)
4.5.3. Propylene Glycol
4.5.3.1. Propylene Glycol Market, 2021 - 2033 (USD Million)
4.5.4. Sorbitol
4.5.4.1. Sorbitol Market, 2021 - 2033 (USD Million)
4.5.5. Mannitol
4.5.5.1. Mannitol Market, 2021 - 2033 (USD Million)
4.5.6. Others
4.5.6.1. Others Market, 2021 - 2033 (USD Million)
4.6. Sugar & Others
4.6.1. Sugar & Others Market, 2021 - 2033 (USD Million)
4.6.2. Lactose
4.6.2.1. Lactose Market, 2021 - 2033 (USD Million)
4.6.3. Sucrose
4.6.3.1. Sucrose Market, 2021 - 2033 (USD Million)
4.6.4. Others
4.6.4.1. Others Market, 2021 - 2033 (USD Million)
4.7. Minerals
4.7.1. Minerals Market, 2021 - 2033 (USD Million)
4.7.2. Calcium Phosphate
4.7.2.1. Calcium Phosphate Market, 2021 - 2033 (USD Million)
4.7.3. Calcium Carbonate
4.7.3.1. Calcium Carbonate Market, 2021 - 2033 (USD Million)
4.7.4. Clay
4.7.4.1. Clay Market, 2021 - 2033 (USD Million)
4.7.5. Silicon Dioxide
4.7.5.1. Silicon Dioxide Market, 2021 - 2033 (USD Million)
4.7.6. Titanium Dioxide
4.7.6.1. Titanium Dioxide Market, 2021 - 2033 (USD Million)
4.7.7. Others
4.7.7.1. Others Market, 2021 - 2033 (USD Million)
4.8. Gelatin
4.8.1. Gelatin Market, 2021 - 2033 (USD Million)
Chapter 5. Middle East Pharmaceutical Excipient Market: Formulation Business Analysis
5.1. Formulation Market Share, 2024 & 2033
5.2. Formulation Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Formulation, 2021 to 2033 (USD Million)
5.4. Oral
5.4.1. Oral Market, 2021 - 2033 (USD Million)
5.5. Topical
5.5.1. Topical Market, 2021 - 2033 (USD Million)
5.6. Parenteral
5.6.1. Parenteral Market, 2021 - 2033 (USD Million)
5.7. Others
5.7.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. Middle East Pharmaceutical Excipient Market: Function Business Analysis
6.1. Function Market Share, 2024 & 2033
6.2. Function Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Function, 2021 to 2033 (USD Million)
6.4. Fillers and Diluents
6.4.1. Fillers and Diluents Market, 2021 - 2033 (USD Million)
6.5. Suspending & Viscosity Agents
6.5.1. Suspending & Viscosity Agents Market, 2021 - 2033 (USD Million)
6.6. Coating Agents
6.6.1. Coating Agents Market, 2021 - 2033 (USD Million)
6.7. Binders
6.7.1. Binders Market, 2021 - 2033 (USD Million)
6.8. Flavoring Agents & Sweeteners
6.8.1. Flavoring Agents & Sweeteners Market, 2021 - 2033 (USD Million)
6.9. Disintegrants
6.9.1. Disintegrants Market, 2021 - 2033 (USD Million)
6.10. Colorants
6.10.1. Colorants Market, 2021 - 2033 (USD Million)
6.11. Lubricants and Glidants
6.11.1. Lubricants and Glidants Market, 2021 - 2033 (USD Million)
6.12. Preservatives
6.12.1. Preservatives Market, 2021 - 2033 (USD Million)
6.13. Emulsifying Agents
6.13.1. Emulsifying Agents Market, 2021 - 2033 (USD Million)
6.14. Others
6.14.1. Others Market, 2021 - 2033 (USD Million)
Chapter 7. Middle East Pharmaceutical Excipient Market: Countries Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2024 & 2033
7.2. Country Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.3.1. UAE
7.3.1.1. Key Country Dynamics
7.3.1.2. Route of Administration Disease Prevalence
7.3.1.3. Regulatory Framework
7.3.1.4. Reimbursement Framework
7.3.1.5. UAE Pharmaceutical Excipient Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.2. Saudi Arabia
7.3.2.1. Key Country Dynamics
7.3.2.2. Route of Administration Disease Prevalence
7.3.2.3. Regulatory Framework
7.3.2.4. Reimbursement Framework
7.3.2.5. Saudi Arabia Pharmaceutical Excipient Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.3. Kuwait
7.3.3.1. Key Country Dynamics
7.3.3.2. Route of Administration Disease Prevalence
7.3.3.3. Regulatory Framework
7.3.3.4. Reimbursement Framework
7.3.3.5. Kuwait Pharmaceutical Excipient Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.4. Qatar
7.3.4.1. Key Country Dynamics
7.3.4.2. Route of Administration Disease Prevalence
7.3.4.3. Regulatory Framework
7.3.4.4. Reimbursement Framework
7.3.4.5. Qatar Pharmaceutical Excipient Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.5. Oman
7.3.5.1. Key Country Dynamics
7.3.5.2. Route of Administration Disease Prevalence
7.3.5.3. Regulatory Framework
7.3.5.4. Reimbursement Framework
7.3.5.5. Oman Pharmaceutical Excipient Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.6. Rest of Middle East
7.3.6.1. Key Country Dynamics
7.3.6.2. Route of Administration Disease Prevalence
7.3.6.3. Regulatory Framework
7.3.6.4. Reimbursement Framework
7.3.6.5. Rest of Middle East Pharmaceutical Excipient Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Eastman Chemical Corporation
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. P&G Chemicals
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Avantor Performance Materials, LLC
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. BASF SE
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Ashland Inc.
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Roquette
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Colorcon Inc.
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Lubrizol Corporation
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. JRS Pharma
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Shin-Etsu Chemical Co., Ltd.
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
8.5.11. DFE Pharma
8.5.11.1. Overview
8.5.11.2. Financial Performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic Initiatives
8.5.12. Finar Limited
8.5.12.1. Overview
8.5.12.2. Financial Performance
8.5.12.3. Product Benchmarking
8.5.12.4. Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us